Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Mackensen

Showing results (51-60 of 231) with videos related to

Pageof 24
Sort By:
Journal of Immunological Methods|April 1, 2009
A new flow cytometric assay for the simultaneous analysis of antigen-specific elimination of T cells in heterogeneous T cell populationsChristian Schütz, Karin Fischer, Simon Völkl, et al.
Mabs|October 19, 2013
A dual-targeting triplebody mediates preferential redirected lysis of antigen double-positive over single-positive leukemic cellsIngo Schubert, Domenica Saul, Stefanie Nowecki, et al.
Journal of Medical Case Reports|October 5, 2011
Persisting right-sided chylothorax in a patient with chronic lymphocytic leukemia: a case reportGodehard A Scholz, Horia Sirbu, Sabine Semrau, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2003
Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patientsNorbert Meidenbauer, Joerg Marienhagen, Monika Laumer, et al.
The Thoracic and Cardiovascular Surgeon|February 19, 2021
Lymphocyte Immune Response and T Cell Differentiation in Fontan Patients with protein-losing enteropathyJulia Moosmann, Okan Toka, Sören Lukassen, et al.
Blood|December 22, 2007
Killer artificial antigen-presenting cells: a novel strategy to delete specific T cellsChristian Schütz, Martin Fleck, Andreas Mackensen, et al.
BMC Complementary Medicine and Therapies|September 8, 2025
TriCAM (NCT02976558) - a randomized controlled pilot study of complementary medicine in allogeneic stem cell transplantation to improve quality of lifeAli Behzad, Stefan W Krause, Andreas Mackensen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
CD8+ T cells reactive to survivin antigen in patients with multiple myelomaMatthias Grube, Stephanie Moritz, Ellen C Obermann, et al.
Bone Marrow Transplantation|May 26, 2018
Depletion of donor-specific anti-HLA A2 alloantibodies in a hematopoietic cell transplant recipient using directed mismatched platelet transfusionsBernd M Spriewald, Christian Bach, Juergen Zingsem, et al.
Nature Medicine|April 22, 2003
Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cellsMathias Oelke, Marcela V Maus, Dominic Didiano, et al.
Pageof 24

Showing results (51-60 of 231) with videos related to

Sort By:
Pageof 24
Journal of Immunological Methods|April 1, 2009
A new flow cytometric assay for the simultaneous analysis of antigen-specific elimination of T cells in heterogeneous T cell populationsChristian Schütz, Karin Fischer, Simon Völkl, et al.
Mabs|October 19, 2013
A dual-targeting triplebody mediates preferential redirected lysis of antigen double-positive over single-positive leukemic cellsIngo Schubert, Domenica Saul, Stefanie Nowecki, et al.
Journal of Medical Case Reports|October 5, 2011
Persisting right-sided chylothorax in a patient with chronic lymphocytic leukemia: a case reportGodehard A Scholz, Horia Sirbu, Sabine Semrau, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2003
Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patientsNorbert Meidenbauer, Joerg Marienhagen, Monika Laumer, et al.
The Thoracic and Cardiovascular Surgeon|February 19, 2021
Lymphocyte Immune Response and T Cell Differentiation in Fontan Patients with protein-losing enteropathyJulia Moosmann, Okan Toka, Sören Lukassen, et al.
Blood|December 22, 2007
Killer artificial antigen-presenting cells: a novel strategy to delete specific T cellsChristian Schütz, Martin Fleck, Andreas Mackensen, et al.
BMC Complementary Medicine and Therapies|September 8, 2025
TriCAM (NCT02976558) - a randomized controlled pilot study of complementary medicine in allogeneic stem cell transplantation to improve quality of lifeAli Behzad, Stefan W Krause, Andreas Mackensen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
CD8+ T cells reactive to survivin antigen in patients with multiple myelomaMatthias Grube, Stephanie Moritz, Ellen C Obermann, et al.
Bone Marrow Transplantation|May 26, 2018
Depletion of donor-specific anti-HLA A2 alloantibodies in a hematopoietic cell transplant recipient using directed mismatched platelet transfusionsBernd M Spriewald, Christian Bach, Juergen Zingsem, et al.
Nature Medicine|April 22, 2003
Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cellsMathias Oelke, Marcela V Maus, Dominic Didiano, et al.
Pageof 24